133 related articles for article (PubMed ID: 11350011)
1. Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary artery.
Cracowski JL; Devillier P; Chavanon O; Sietchiping-Nzepa FA; Stanke-Labesque F; Bessard G
Life Sci; 2001 Apr; 68(21):2405-13. PubMed ID: 11350011
[TBL] [Abstract][Full Text] [Related]
2. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
Cracowski JL; Stanke-Labesque F; Devillier P; Chavanon O; Hunt M; Souvignet C; Bessard G
Eur J Pharmacol; 2000 May; 397(1):161-8. PubMed ID: 10844110
[TBL] [Abstract][Full Text] [Related]
3. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts.
Möbert J; Becker BF; Zahler S; Gerlach E
J Cardiovasc Pharmacol; 1997 Jun; 29(6):789-94. PubMed ID: 9234660
[TBL] [Abstract][Full Text] [Related]
5. Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II.
Sametz W; Grobuschek T; Hammer-Kogler S; Juan H; Wintersteiger R
Eur J Pharmacol; 1999 Jul; 378(1):47-55. PubMed ID: 10478564
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
[TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle.
Tazzeo T; Miller J; Janssen LJ
Br J Pharmacol; 2003 Oct; 140(4):759-63. PubMed ID: 14504139
[TBL] [Abstract][Full Text] [Related]
8. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
Sametz W; Hennerbichler S; Glaser S; Wintersteiger R; Juan H
Br J Pharmacol; 2000 Aug; 130(8):1903-10. PubMed ID: 10952681
[TBL] [Abstract][Full Text] [Related]
9. Effect of the isoprostanes, 8-iso prostaglandin E2 and 8-iso prostaglandin F2 alpha on the rabbit lung in vivo.
Hill AA; Coleman RA; Taylor GW; Moore KP; Taylor IK
Prostaglandins; 1997 Feb; 53(2):69-82. PubMed ID: 9112286
[TBL] [Abstract][Full Text] [Related]
10. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
[TBL] [Abstract][Full Text] [Related]
11. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles.
Hoffman SW; Moore S; Ellis EF
Stroke; 1997 Apr; 28(4):844-9. PubMed ID: 9099206
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
Jourdan KB; Evans TW; Curzen NP; Mitchell JA
Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
[TBL] [Abstract][Full Text] [Related]
13. Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.
Daray FM; Colombo JR; Kibrik JR; Errasti AE; Pelorosso FG; Nowak W; Cracowski JL; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2006 Aug; 373(5):367-75. PubMed ID: 16738877
[TBL] [Abstract][Full Text] [Related]
14. Formation of 8-isoprostaglandin F2alpha and prostaglandin E2 in carrageenan-induced air pouch model in rats.
Ciçek Ozdöl N; Melli M
Eur J Pharmacol; 2004 Dec; 506(2):189-97. PubMed ID: 15588740
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels.
Lahaie I; Hardy P; Hou X; Hasséssian H; Asselin P; Lachapelle P; Almazan G; Varma DR; Morrow JD; Roberts LJ; Chemtob S
Am J Physiol; 1998 May; 274(5):R1406-16. PubMed ID: 9612409
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G
Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074
[TBL] [Abstract][Full Text] [Related]
17. Isoprostanes and the kidney.
Badr KF; Abi-Antoun TE
Antioxid Redox Signal; 2005; 7(1-2):236-43. PubMed ID: 15650411
[TBL] [Abstract][Full Text] [Related]
18. The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO.
Minuz P; Andrioli G; Degan M; Gaino S; Ortolani R; Tommasoli R; Zuliani V; Lechi A; Lechi C
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1248-56. PubMed ID: 9714131
[TBL] [Abstract][Full Text] [Related]
19. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
Janssen LJ; Tazzeo T
J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of sympathetic neurotransmission in bovine isolated irides by isoprostanes.
Opere CA; Awe SO; Harris LC; LeDay AM; Ohia SE
Free Radic Res; 2001 Sep; 35(3):257-64. PubMed ID: 11697124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
